Specifically, in diseases such as RA and SLE, OX40 signaling enhances the activity of pro-inflammatory T-helper subsets, including Th1 and Th17 cells, thereby perpetuating synovial inflammation and joint destruction. The gene discussed is TNFRSF4; the disease is systemic lupus erythematosus.